ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,615, issued on May 19, was assigned to THE BRIGHAM AND WOMEN'S HOSPITAL INC. (Boston) and SANOFI (Paris).

"Neutralizing anti-amyloid beta antibodies for the treatment of Alzheimer's disease" was invented by Ming Jin (Boston), Laurent Pradier (Paris), David Reczek (Bridgewater, N.J.), Dennis Selkoe (Boston), Tara Travaline (Bridgewater, N.J.) and Dominic Walsh (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Binding polypeptides (e.g., antibodies and antigen-binding fragments thereof) that specifically bind one or more species of soluble, AD brain-derived synaptotoxic amyloid beta (ABeta) without binding to classical monomeric, protofibrillar or...